Early diagnosis of eye disease with better retinal imaging

Article

Collaborative research has led to the development of an adaptive optics-optical coherence tomography (AO-OCT) system that allows ophthalmologists to see the eye's retina at the individual level.

Collaborative research has led to the development of an adaptive optics-optical coherence tomography (AO-OCT) system that allows ophthalmologists to see the eye's retina at the individual level.

Researchers at the Lawrence Livermore National Lab (LLNL), the Indiana University School of Optometry, Boston Micromachines and the University of California, Davis have built three AO-OCT instruments with the help of the National Eye Institute. These devices provide non-invasive, ultra-high resolution, three-dimensional volumetric retinal images for ophthalmologists and optometrists to view the cellular level structure in the human retina. This capability is expected to allow doctors to diagnose retinal diseases early and follow their progression as well as track the progress of genetic therapies that reverse the diseases.

Using the same principles that allow astronomers to view distant objects the device reportedly represents a revolutionary advancement over current instruments.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.